Bristol-Myers Squibb India Profile
Key Indicators
- Authorised Capital ₹ 350.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 346.91 Cr
as on 11-07-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 20.72%
(FY 2022)
- Profit 327.60%
(FY 2022)
- Ebitda 277.61%
(FY 2022)
- Net Worth 22.47%
(FY 2022)
- Total Assets 18.39%
(FY 2022)
About Bristol-Myers Squibb India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 350.00 Cr and a paid-up capital of Rs 346.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bristol-Myers Squibb India Private Limited India is Narendra Mundra as COMPANY SECRETARY. Srivatsan Krishnan, Sanjay Sharma, and Raghavendra Agarwal serve as directors at the Company.
- CIN/LLPIN
U24230MH2004FTC147232
- Company No.
147232
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
30 Jun 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bristol-Myers Squibb India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Mundra  | Company Secretary | 23-Mar-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghavendra Agarwal | Director | 09-Oct-2014 | Current |
Srivatsan Krishnan  | Director | Current | |
| Sanjay Sharma | Director | 24-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Bristol-Myers Squibb India.
Bristol-Myers Squibb India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.72% increase. The company also saw a substantial improvement in profitability, with a 327.6% increase in profit. The company's net worth Soared by an impressive increase of 22.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bristol-Myers Squibb India?
In 2022, Bristol-Myers Squibb India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bristol-Myers Squibb Business Services India Private LimitedActive 1 year 6 monthsRaghavendra Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bristol-Myers Squibb India?
Unlock and access historical data on people associated with Bristol-Myers Squibb India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bristol-Myers Squibb India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bristol-Myers Squibb India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
